majority of TBI and stroke studies Mice Used for transgenic Alzheimers models (APP, APP/PS1) and excitotoxicity studies Humans Multiple clinical trials in stroke, dementia, and TBI populations Cell culture Cortical neurons, hippocampal cultures, endothelial cells for mechanistic studies Research Limitations & Regulatory Status Critical Gaps in Current Evidence Despite over 1,000 preclinical studies and numerous clinical trials, Cerebrolysin faces substantial translational challenges that significantly limit its therapeutic utility
It is highly expressed in growth cones during axonal elongation, neural regeneration, and synaptic remodeling
Penetrating the follicle deeply enough to reach melanocytes remains a biological challenge
In a different model, amoeba cells treated only with kavalactones demonstrated high toxicity, leading to total cell death
Early intervention and addressing deficiencies are key to maintaining healthy bodily function